# GlyT-1 Inhibitor Treatment for Refractory Schizophrenia

> **NCT01251055** · PHASE2 · COMPLETED · sponsor: **China Medical University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Schizophrenia
- Treatment Refractory

## Interventions

- **DRUG:** GlyT-1 inhibitor-1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01251055
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01251055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01251055, "GlyT-1 Inhibitor Treatment for Refractory Schizophrenia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01251055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*